ClinicalTrials.govpublic full text
An Open Label Study to Evaluate Safety, Tolerability and Clinical Utility of ULTRACET® (37.5mg Tramadol Hydrochloride/325mg Acetaminophen) for the Treatment of Breakthrough Pain in Cancer Patients
pain, cancer pain, breakthrough pain, acetaminophen, tramadol hydrochloride, ultracet, interventional, phase4
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 877443
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.